---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-001228"
form_type: "8-K"
ticker: "AVTX"
cik: "0001534120"
company_name: "Avalo Therapeutics, Inc."
filed_at: "2025-01-13T23:59:59+00:00"
generated_at: "2026-05-28T03:15:39.101442+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Avalo Therapeutics posts updated investor presentation; no specific financial details disclosed

## Summary
- Avalo posted an updated corporate presentation on its website on Jan 13, 2025.
- The filing does not disclose any specific financial, pipeline, or strategic updates from the presentation.
- No new earnings, guidance, or material events were announced in connection with the posting.
- The only document attached is the presentation cover slide; investors must access the full deck for details.

## SEC filing metadata
- accession: 0001628280-25-001228
- form_type: 8-K
- ticker: AVTX
- cik: 0001534120
- company_name: Avalo Therapeutics, Inc.
- filed_at: 2025-01-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1534120/000162828025001228/0001628280-25-001228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1534120/000162828025001228/avtx-20250113.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-001228
- JSON: https://secwatch.observer/filing/0001628280-25-001228.json
- Plain text: https://secwatch.observer/filing/0001628280-25-001228.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.